Voyager COO Swartz Robin’s Sell‑to‑Cover Trade: Insider Confidence Signals Long‑Term Growth
Voyager Therapeutics COO Swartz Robin’s sell‑to‑cover sale of 4,569 shares to cover RSU taxes shows routine insider liquidity management while retaining long‑term stake.
3 minutes to read